Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Treatment for MRSA no longer more costly than for susceptible Staph aureus infections

europeanpharmaceuticalreviewMay 15, 2018

Tag: mrsa , cost , susceptible Staph aureus infections , MSSA

PharmaSources Customer Service